Neurovalens receives second FDA approval

April 16, 2024

In November 2023, the team received FDA medical device approval for their Modius Sleep device which means that it is now considered a Class II medical device that can be prescribed in the US as a treatment for chronic insomnia. In another exciting advancement, today the team has announced that they have received FDA approval for their stress reduction device.